about
Drug delivery of the future: Chasing the invisible gorillaBiological interactions of carbon-based nanomaterials: From coronation to degradation.Multiple cues on the physiochemical, mesenchymal, and intracellular trafficking interactions with nanocarriers to maximize tumor target efficiencyTargeted nanotechnology for cancer imaging.Heterogeneous Uptake of Nanoparticles in Mouse Models of Pediatric High-Risk NeuroblastomaPolymeric Nanostructures for Imaging and TherapyIntelligent recognitive systems in nanomedicine.Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes.Controlled drug delivery systems: past forward and future back.Therapeutic interventions in sepsis: current and anticipated pharmacological agentsSelf-assembled Targeting of Cancer Cells by Iron(III)-doped, Silica NanoparticlesAEG-1 promoter-mediated imaging of prostate cancer.Simulation of complex transport of nanoparticles around a tumor using tumor-microenvironment-on-chip.Shape Transformation Following Reduction-Sensitive PEG Cleavage of Polymer/DNA Nanoparticles.Smart Nanoparticles for Drug Delivery: Boundaries and OpportunitiesShape Control in Engineering of Polymeric Nanoparticles for Therapeutic Delivery.Accumulation and Toxicity of Superparamagnetic Iron Oxide Nanoparticles in Cells and Experimental Animals.Controlled Drug Delivery: Historical perspective for the next generation.Suppression of Rituximab-resistant B-cell lymphoma with a novel multi-component anti-CD20 mAb nanocluster.Critical Length of PEG Grafts on lPEI/DNA Nanoparticles for Efficient in Vivo Delivery.Photodynamic Therapy Induced Enhancement of Tumor Vasculature Permeability Using an Upconversion Nanoconstruct for Improved Intratumoral Nanoparticle Delivery in Deep TissuesNanocarrier-based immunotherapy in cancer management and research.Principles of nanoparticle design for overcoming biological barriers to drug deliveryImage-Guided Radiotherapy Targets Macromolecules through Altering the Tumor Microenvironment.Drug Delivery Research: The Invention Cycle.Theranostic nanoparticles for cancer and cardiovascular applications.Advances in targeting strategies for nanoparticles in cancer imaging and therapy.Differences in physicochemical properties to consider in the design, evaluation and choice between microparticles and nanoparticles for drug delivery.In vitro microfluidic models of tumor microenvironment to screen transport of drugs and nanoparticles.Development of nanotoxicology: implications for drug delivery and medical devices.Interaction between drug delivery vehicles and cells under the effect of shear stress.Reciprocal upregulation of scavenger receptors complicates interpretation of nanoparticle uptake in non-phagocytic cells.Recapitulation of complex transport and action of drugs at the tumor microenvironment using tumor-microenvironment-on-chip.Magnetite nanoparticles for cancer diagnosis, treatment, and treatment monitoring: recent advances.Emerging nanotechnologies for cancer immunotherapyInnovative use of the taxol binding peptide overcomes key challenges of stable and high drug loading in polymeric nanomicelles.Enhancing Accumulation and Penetration of HPMA Copolymer-Doxorubicin Conjugates in 2D and 3D Prostate Cancer Cells via iRGD Conjugation with an MMP-2 Cleavable Spacer.Coadministration of Vascular Disrupting Agents and Nanomedicines to Eradicate Tumors from Peripheral and Central Regions.Evaluation of a PSMA-targeted BNF nanoparticle construct.A computational framework for interspecies pharmacokinetics, exposure and toxicity assessment of gold nanoparticles.
P2860
Q24289432-F026E44B-98FC-4C02-8D3F-F273E6F657AEQ26771906-B2A45D72-B246-412D-8F77-75F4B502C322Q26827999-D476EFE8-2F48-41AA-B1F3-F8951DABC2DEQ27010317-9C068C68-14B2-4271-ACBE-D3B8955DDA62Q28553602-3E352B28-FD7B-465B-8EFC-BD7B9A0945EEQ30372383-1ADCB1F5-E7B9-442E-8649-6D691DBBB45BQ33632768-98A0FB7B-BA92-420E-B16E-D41AA15CFF0DQ33811463-DBC0769F-31F0-4867-B3FA-99C43E66171BQ34079613-44FC00C1-39BE-4CD4-BF46-BA08592A15ACQ34427050-160D929E-AFF7-4026-9FC6-F1D418A83030Q34427093-96C8B831-9597-4140-8B58-684B3D9BCAF6Q34522714-6820FE27-81A2-4E93-9217-F36624C16F51Q34613544-2CC3C593-5551-473F-A48A-74131B0C4204Q34727867-78687F5F-C3D5-4ABA-A18F-176CD91E6C0DQ35067230-2C819329-A04E-4829-8224-84A46D2D14D1Q35801327-125D21EE-8F0D-47DC-BC76-6CE00D1A2092Q36108983-4D614A0A-0F11-4FBD-9518-60ACE613B3D1Q36307613-B0485B65-7D03-4D2B-93F5-BFB4DE5C6611Q36414417-9DAF72E0-5FBF-4321-B998-4F67B14525A7Q36793350-30C70E5D-9C46-47C8-8B80-E0486C697C34Q36970360-99164D7A-54C8-47D5-ABEB-F3405C674DD9Q37031671-061D4879-A6D5-417B-93F2-21D3ECE1560AQ37162182-C9AF4E0B-1E60-45E8-9E08-A3A2C333FAD9Q37405788-9406D266-8A3E-4D36-827E-98D27427514FQ37659183-DB2DA057-1892-4C88-867A-20D675CD18BDQ38193333-912DEDC8-0EC9-4553-A63D-E7190A221DFFQ38255901-4AEA6F52-5E52-4D03-9E99-84629AB2ACC5Q38291341-D6372B0F-124B-40DF-A844-F4D7E0168028Q38405765-C2660735-7EE8-4653-8BFB-37BDF2545EDDQ38538525-2FDBCF4E-D4A6-4AB0-8FA6-B905B2B773C6Q38548252-E95EBA51-5DC9-4E5F-B3D5-7C62ED6AD5B3Q38652193-3F0C30CA-0E34-4624-8BB0-5791FF55AE4CQ38674749-1E641C88-5949-4F30-9C8F-D90FAEDEECD6Q38831346-899D1B80-9D52-4C55-A9EC-002567802F7FQ38837036-6F82D400-F532-48D7-89EF-82B43ED0DE10Q38859051-CFB21681-D442-45AE-B5B0-E64C85F7AEB3Q38876382-0FB576FF-C7F3-48F3-A54B-FD7A11346B12Q38881452-B8B6114E-0AB8-45CF-80E5-0A7AB5BE0B87Q38910401-8B469D25-3CAD-4FD4-ACAF-B2CC79268B2AQ38933494-B036140F-E183-490E-B6F0-71AAB0945F0A
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Facing the truth about nanotechnology in drug delivery.
@en
Facing the truth about nanotechnology in drug delivery.
@nl
type
label
Facing the truth about nanotechnology in drug delivery.
@en
Facing the truth about nanotechnology in drug delivery.
@nl
prefLabel
Facing the truth about nanotechnology in drug delivery.
@en
Facing the truth about nanotechnology in drug delivery.
@nl
P2860
P356
P1433
P1476
Facing the truth about nanotechnology in drug delivery.
@en
P2093
Kinam Park
P2860
P304
P356
10.1021/NN404501G
P407
P577
2013-09-01T00:00:00Z